Jörg T. Regula

3.7k total citations · 1 hit paper
37 papers, 2.9k citations indexed

About

Jörg T. Regula is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jörg T. Regula has authored 37 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Jörg T. Regula's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (15 papers) and Protein purification and stability (10 papers). Jörg T. Regula is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (15 papers) and Protein purification and stability (10 papers). Jörg T. Regula collaborates with scholars based in Germany, Switzerland and United Kingdom. Jörg T. Regula's co-authors include Christian Haass, Christian Klein, Harald Steiner, Dieter Edbauer, Brigitte Pesold, Edith Winkler, Wolfgang Schaefer, Hubert Kettenberger, Kay Stubenrauch and Axel Imhof and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Jörg T. Regula

37 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reconstitution of γ-secretase activity

2003 726 citations Jörg T. Regula, Christian Haass et al. profile →

Peers

Countries citing papers authored by Jörg T. Regula

Since Specialization

Citations

This map shows the geographic impact of Jörg T. Regula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg T. Regula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg T. Regula more than expected).

Fields of papers citing papers by Jörg T. Regula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg T. Regula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg T. Regula. The network helps show where Jörg T. Regula may publish in the future.

Co-authorship network of co-authors of Jörg T. Regula

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg T. Regula. A scholar is included among the top collaborators of Jörg T. Regula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg T. Regula. Jörg T. Regula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering therapeutic bispecific antibodies using CrossMab technology 2018 ·Methods ·Christian Klein, Wolfgang Schaefer, Jörg T. Regula, Charles Dumontet, Ulrich Brinkmann, Marina Bacac, Pablo Umaña	99
2	Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases 2017 ·EMBO Molecular Medicine ·Jörg T. Regula, Peter Lundh von Leithner, Richard M. FOXTON, Veluchamy A. Barathi, Chui Ming Gemmy Cheung, Sai Bo Bo Tun, Yeo Sia Wey, Daiju Iwata, Miroslav Dostálek, Jörg Moelleken, Kay Stubenrauch, Everson Nogoceke, Gabriella Widmer, Pamela Strassburger, Michael Koss, Christian Klein, David T. Shima, Guido Hartmann	7
3	What is the biologically relevant KD for VEGF binding to ranibizumab in the eye? A comparison of in-vivo and in-vitro estimates. 2016 ·Investigative Ophthalmology & Visual Science ·Norman A. Mazer, Dietmar Schwab, (unknown), Helen M. Byrne, Eamonn A. Gaffney, Philip K. Maini, Guido Hartmann, (unknown), Christian Gassner, Jörg T. Regula	3
4	SPR-based assays enable the full functional analysis of bispecific molecules 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Christian Gassner, Florian Lipsmeier, Jörg T. Regula, Jörg Moelleken	8
5	Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases 2016 ·EMBO Molecular Medicine ·Jörg T. Regula, Peter Lundh von Leithner, Richard Foxton, Veluchamy A. Barathi, Chui Ming Gemmy Cheung, Sai Bo Bo Tun, Yeo Sia Wey, Daiju Iwata, Miroslav Dostálek, Jörg Moelleken, Kay Stubenrauch, Everson Nogoceke, Gabriella Widmer, Pamela Strassburger, Michael Koss, Christian Klein, David T. Shima, Guido Hartmann	241
6	Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry 2015 ·mAbs ·Wolfgang Schaefer, (unknown), Stefan Lorenz, Sabine Imhof-Jung, Jörg T. Regula, Christian Klein, Michael Mølhøj	27
7	Developability Assessment During the Selection of Novel Therapeutic Antibodies 2015 ·Journal of Pharmaceutical Sciences ·A. Jarasch, Hans Koll, Jörg T. Regula, Martin Bader, Apollon Papadimitriou, Hubert Kettenberger	172
8	Dual inhibition of angiopoietin-2 and vascular endothelial growth factor-A with Crossmab RG7716 suppressed laser-induced choroidal neovascularization in a non-human primate model 2014 ·Investigative Ophthalmology & Visual Science ·Chui Ming Gemmy Cheung, Veluchamy A. Barathi, Sai Bo Bo Tun, (unknown), Pei Pei Gan, (unknown), Jörg T. Regula, (unknown)	4
9	Development and validation of a novel SPR-based assay principle for bispecific molecules 2014 ·Journal of Pharmaceutical and Biomedical Analysis ·Christian Gassner, Florian Lipsmeier, (unknown), Hans‐Peter Beck, (unknown), Jörg T. Regula, Jörg Moelleken	21
10	Bispecific anti-VEGF/ANG2 antibody exhibits superior efficacy to VEGF monotherapy in a model of spontaneous CNV 2014 ·Investigative Ophthalmology & Visual Science ·Peter Lundh von Leithner, Daiju Iwata, Yin‐Shan Ng, Jörg T. Regula, Guido Hartmann, David T. Shima	1
11	Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies 2012 ·mAbs ·Christian Klein, Claudio Sustmann, Markus Thomas, Kay Stubenrauch, Rebecca Croasdale, Jürgen Schanzer, Ulrich Brinkmann, Hubert Kettenberger, Jörg T. Regula, Wolfgang Schaefer	157
12	Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach 2012 ·PLoS ONE ·Anne Zeck, Jörg T. Regula, Vincent Larraillet, (unknown), (unknown), Ulrich Göpfert, (unknown), (unknown), Ingo H. Gorr, Hans Koll, Apollon Papadimitriou	32
13	Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies 2011 ·Proceedings of the National Academy of Sciences ·Wolfgang Schaefer, Jörg T. Regula, Monika Bähner, Jürgen Schanzer, Rebecca Croasdale, Harald Dürr, Christian Gassner, Guy Georges, Hubert Kettenberger, Sabine Imhof-Jung, Manfred Schwaiger, Kay Stubenrauch, Claudio Sustmann, Markus Thomas, Werner Scheuer, Christian Klein	334
14	A Human Neutralizing Antibody Specific to Ang‐2 Inhibits Ocular Angiogenesis 2011 ·Microcirculation ·Emma Rennel, Jörg T. Regula, Steven J. Harper, Markus Thomas, Christian Klein, David O. Bates	27
15	Impact of Molecular Processing in the Hinge Region of Therapeutic IgG4 Antibodies on Disposition Profiles in Cynomolgus Monkeys 2009 ·Drug Metabolism and Disposition ·Kay Stubenrauch, Uwe Wessels, Jörg T. Regula, Hubert Kettenberger, Julia Schleypen, Ulrich Kohnert	37
16	Analysis of the major proteins secreted by the human opportunistic pathogenAspergillus fumigatusunderin vitroconditions 2005 ·Medical Mycology ·(unknown), Michael Weig, Svenja Thies, Jörg T. Regula, Jürgen Heesemann, Frank Ebel	42
17	A combination of different mass spectroscopic techniques for the analysis of dynamic changes of histone modifications 2004 ·PROTEOMICS ·Tiziana Bonaldi, Axel Imhof, Jörg T. Regula	94
18	Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1 2004 ·Journal of Biological Chemistry ·Karin Görner, (unknown), Sabine Odoy, Brigitte Nuscher, Ayako Yamamoto, Jörg T. Regula, Klaus Beyer, Christian Haass, Philipp J. Kahle	76
19	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists 2004 ·The EMBO Journal ·Christof Haffner, (unknown), Stephanie D. Topp, Martin Irmler, Kay Hofmann, Jörg T. Regula, Laure Bally‐Cuif, Christian Haass	54
20	The Use of Mass Spectrometry for the Analysis of Histone Modifications 2003 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Tiziana Bonaldi, Jörg T. Regula, Axel Imhof	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact